Karuna Therapeutics, Inc. Annual Share-based Payment Arrangement, Expense in USD from 2018 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Karuna Therapeutics, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from 2018 to 2023.
  • Karuna Therapeutics, Inc. Share-based Payment Arrangement, Expense for the quarter ending December 31, 2023 was $38.3M, a 64.4% increase year-over-year.
  • Karuna Therapeutics, Inc. Share-based Payment Arrangement, Expense for the twelve months ending December 31, 2023 was $74.6M, a 57.2% increase year-over-year.
  • Karuna Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $74.6M, a 57.2% increase from 2022.
  • Karuna Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $47.5M, a 59.2% increase from 2021.
  • Karuna Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2021 was $29.8M, a 121% increase from 2020.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $74.6M +$27.1M +57.2% Jan 1, 2023 Dec 31, 2023 10-K 2024-02-22
2022 $47.5M +$17.6M +59.2% Jan 1, 2022 Dec 31, 2022 10-K 2024-02-22
2021 $29.8M +$16.3M +121% Jan 1, 2021 Dec 31, 2021 10-K 2024-02-22
2020 $13.5M +$903K +7.19% Jan 1, 2020 Dec 31, 2020 10-K 2023-02-23
2019 $12.6M +$11.6M +1212% Jan 1, 2019 Dec 31, 2019 10-K 2022-02-24
2018 $958K Jan 1, 2018 Dec 31, 2018 10-K 2021-02-25
* An asterisk sign (*) next to the value indicates that the value is likely invalid.